In addition, other studies have shown that the overexpression of CBX3 in osteosarcoma (13), tongue squamous carcinoma (14) and breast cancer (15) can adversely affect the prognosis by promoting the occurrence as well as the development of tumors. This evidence concerns the gene CBX3 and breast carcinoma.